PNAA
GSK icon

Pictet North America Advisors’s GSK GSK Stock Holding History

Pictet North America Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,440
Closed -$440K – 167
2018
Q2 		$440K Hold
17,440
– – 0.07% 99
2018
Q1 		$426K Buy
+17,440
New +$812K 0.06% 100

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pictet North America Advisors's GSK Position: Q3 2018 in Review

Pictet North America Advisors sold out of GSK (GSK) in Q3 2018, closing a stake of 17,440 shares — an estimated $440K sold.

Pictet North America Advisors first reported a position in GSK in Q1 2018 and held it in 2 quarters. The position peaked at $440K in Q2 2018. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

  • Pictet North America Advisors reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
  • Pictet North America Advisors sold 17,440 GSK shares in Q3 2018, an estimated $440K.
  • Pictet North America Advisors first reported a position in GSK in Q1 2018 and held it in 2 quarters.
  • Pictet North America Advisors's GSK position peaked at $440K in Q2 2018.
  • 787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Pictet North America Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.